Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patients

Leukemia. 2021 Nov;35(11):3287-3290. doi: 10.1038/s41375-021-01237-x. Epub 2021 Apr 5.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Chromosome Aberrations*
  • Chromosomes, Human, Pair 2 / genetics*
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Gene Dosage*
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Male
  • Middle Aged
  • Piperidines / therapeutic use*
  • Prognosis
  • Survival Rate

Substances

  • Piperidines
  • ibrutinib
  • Adenine